Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer

Apmis ◽  
2009 ◽  
Vol 117 (10) ◽  
pp. 755-761 ◽  
Author(s):  
CHARLOTTE ELBERLING ALMASI ◽  
GUNILLA HØYER-HANSEN ◽  
IB JARLE CHRISTENSEN ◽  
HELLE PAPPOT
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Plasminogen Activator ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Urokinase Plasminogen Activator ◽  
Small Cell ◽  
Small Cell Lung ◽  
Urokinase Plasminogen Activator Receptor ◽  
Plasminogen Activator Receptor

Pretreatment Determination of the Serum Urokinase Plasminogen Activator and its Soluble Receptor in Advanced Small-Cell Lung Cancer or Non-Small-Cell Lung Cancer

2003 ◽  
Vol 9 (3) ◽  
pp. 241-246 ◽  
Author(s):  
Everardo Cobos ◽  
Cynthia Jumper ◽  
Charles Lox
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Plasminogen Activator ◽  
Cell Lung Cancer ◽  
Urokinase Plasminogen Activator ◽  
Small Cell ◽  
Stage Iii ◽  
Enzyme Linked Immunosorbent Assay ◽  
Soluble Receptor ◽  
Small Cell Lung

This study was undertaken to evaluate the circulating urokinase plasminogen activator (uPA), and its soluble receptor (suPAR) in patients with either small-cell lung cancer (SCLC) or non-small-cell lung cancer (NSCLC). Thirty-one male and female patients with stage III or IV NSCLC and 17 with stage III or IV SCLC were compared to 138 age-matched non-smoking controls of both sexes. Before any treatment was undertaken, serum was obtained and evaluated for its content of uPA and suPAR with enzyme-linked immunosorbent assay. The results indicated a wide variation in serum uPA content that was not significant, while extremely significant increases in suPAR were found. The natural physiologic relationship between uPA and its receptor was lost in both SCLC and NSCLC, which could indicate abnormal alterations of uPA suPAR, suggesting these factors aid in the process of invasion and metastasis of lung cancer.

Prognostic Significance of Perioperative C-Reactive Protein in Resected Non-Small Cell Lung Cancer

2020 ◽  
Vol 32 (4) ◽  
pp. 1046-1055 ◽  
Author(s):  
Satoru Okada ◽  
Masanori Shimomura ◽  
Hiroaki Tsunezuka ◽  
Satoshi Teramukai ◽  
Shunta Ishihara ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Small Cell ◽  
C Reactive Protein ◽  
Small Cell Lung ◽  
Reactive Protein

The Prognostic Significance of Circulating Tumour Cells in Head and Neck and Non-Small Cell Lung Cancer

2018 ◽  
Author(s):  
Arutha Kulasinghe ◽  
Joanna Kapeleris ◽  
Rebecca Kimberley ◽  
Stephen R Mattarollo ◽  
Erik W Thompson ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Head And Neck ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Small Cell ◽  
Tumour Cells ◽  
Circulating Tumour Cells ◽  
Small Cell Lung

scholarly journals P72.10 Prognostic Significance of IgA+ B Cells in Non-Small Cell Lung Cancer

2021 ◽  
Vol 16 (3) ◽  
pp. S569
Author(s):  
M. Vanderputten ◽  
F. Aboubakar ◽  
C. Bouzin ◽  
D. Hoton ◽  
C. Stanciu Pop ◽  
...  
Keyword(s):  
Lung Cancer ◽  
B Cells ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Small Cell ◽  
Small Cell Lung

Patterns and prognostic significance of cutaneous immune-related adverse events in non–small cell lung cancer

2021 ◽  
Vol 147 ◽  
pp. 13-16
Author(s):  
Leah L. Thompson ◽  
Emily R. Nadelmann ◽  
Amy E. Blum ◽  
Jaewon Yoon ◽  
Nicole J. Polyakov ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Adverse Events ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Prognostic Significance ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document